| Article Access Statistics | | | Viewed | 8396 | | | Printed | 290 | | | Emailed | 8 | | | PDF Downloaded | 242 | | | Comments | [Add] | | | Cited by others | 24 | | |
|
Click on image for details.
|
|
| ORIGINAL ARTICLE |
|
|
|
| Year : 2010 | Volume
: 56
| Issue : 1 | Page : 3-6 |
Association of systemic risk factors with the severity of retinal hard exudates in a north Indian population with type 2 diabetes
N Sachdev1, A Sahni2
1 Department of Ophthalmology, Post Graduate Institute of Medical Education and Research, Chandigarh, India
2 Department of Ophthalmology, Govt. Medical College and Hospital, Chandigarh, India
| Date of Submission | 21-Jul-2009 |
| Date of Decision | 12-Jan-2010 |
| Date of Acceptance | 27-Jan-2010 |
| Date of Web Publication | 12-Apr-2010 |
Correspondence Address:
N Sachdev
Department of Ophthalmology, Post Graduate Institute of Medical Education and Research, Chandigarh
India
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/0022-3859.62419
Background: The various risk factors for diabetic retinopathy and its spectrum are still poorly understood in the Indian population. Aims: To study the association of various systemic risk factors with retinal hard exudates in type 2 diabetic north Indian patients and to measure the incidence of dyslipidemia in them. Settings and Design: A tertiary-hospital-based cross-sectional study. Materials and Methods: An observational case-study which included 180 type 2 diabetic patients (180 eyes) of nonproliferative diabetic retinopathy (NPDR) with clinically significant macular edema (CSME). In these patients the retinal hard exudates were graded on a central 500 fundus picture using modified Airlie House classification and divided into three groups of absent or minimal hard exudates (Group 1), hard exudates present (Group 2) and prominent hard exudates (Group 3). Their association with various risk factors, namely the age of onset of diabetes and its duration, gender, insulin therapy, and various systemic parameters like hypertension, blood hemoglobin, glycosylated hemoglobin, serum (s.) creatinine levels, 24-h proteinuria and complete lipid profile including total s. cholesterol, low-density lipoprotein cholesterol (LDL), high-density lipoprotein cholesterol (HDL), very low-density lipoprotein cholesterol (VLDL) and s. triglyceride (TG) was studied. The incidence of dyslipidemia was also calculated among these groups of patients. Statistical Analysis: ANOVA test, linear regression analysis and Spearman's correlation test. Results: On univariate analysis, the retinal hard exudates were significantly associated with s. creatinine (P=0.016), systolic blood pressure (P=0.014), s. cholesterol (P<0.001), s. LDL (P=0.008) and s. TG (P=0.013) levels. While on linear regression analysis, s. cholesterol (P<0.001) and s. LDL cholesterol (P=0.028) were found to be independent risk factors affecting the density of retinal hard exudates. On Spearman's correlation test, the retinal hard exudates showed a significant positive correlation with systolic blood pressure (P=0.019), s. cholesterol (P<0.001), LDL (P=0.002) and TG (P=0.014) levels. The incidence of dyslipidemia varied from as high as nearly 70% among patients of Group 3 compared to as low as 18% among Group 1 patients. Conclusion: Serum cholesterol and LDL are independent risk factors for retinal hard exudates in type 2 diabetic north Indian patients who suffer from a remarkably high incidence of dyslipidemia.
Keywords: Diabetic retinopathy, hard exudates, lipid profile
How to cite this article:
Sachdev N, Sahni A. Association of systemic risk factors with the severity of retinal hard exudates in a north Indian population with type 2 diabetes. J Postgrad Med 2010;56:3-6 |
How to cite this URL:
Sachdev N, Sahni A. Association of systemic risk factors with the severity of retinal hard exudates in a north Indian population with type 2 diabetes. J Postgrad Med [serial online] 2010 [cited 2023 Jun 6];56:3-6. Available from: https://www.jpgmonline.com/text.asp?2010/56/1/3/62419 |
Clinically significant macular edema (CSME) is the most common cause of moderate visual loss in nonproliferative diabetic retinopathy (NPDR). [1] CSME is defined as retinal thickening at or within 500 microns from the centre of macula, hard exudates at or within 500 microns from the centre of macula, if there is thickening of the adjacent retina or presence of an area or areas of retinal thickening at least 1 disc area in size, at least a part of which is within 1 disc diameter of the centre of the macula. [1],[2] Hence, retinal hard exudates are one of a constellation of retinal lesions that characterize diabetic retinopathy and CSME. [2]
Various previous studies on retinal hard exudates and their risk factors have been conducted on Caucasian and black American populations. [3],[4],[5],[6],[7],[8] However, recent studies have suggested that Indians, especially the north Indian population, is more predisposed to develop diabetes and its related complications. [9],[10],[11],[12],[13],[14] Hence, we conducted a study to determine the association between various systemic risk factors and severity of retinal hard exudates among type 2 diabetic north Indian patients. We also studied the incidence of dyslipidemia in these patients.
| :: Materials and Methods | |  |
This observational tertiary-hospital-based cross-sectional case-study enrolled 180 consecutive patients with type 2 diabetes mellitus having CSME and NPDR in at least one eye attending the Retina Clinic of our institute. The study was approved by the ethical review board of the institute and a written informed consent was obtained from all the participating patients. All the subjects underwent a detailed ocular examination, including recording of best-corrected visual acuity and a dilated fundus examination. Single eye was enrolled for each patient and in patients in whom both the eyes fulfilled the inclusion criteria, the eye with the poorer vision was assigned to the patient. However, eyes with significant media haze preventing adequate visualization of the fundus to permit grading of hard exudates were excluded from the study.
The grading of retinal hard exudates was performed by utilizing the modified Airlie House Classification on a central 50° digital fundus photograph. [15] The modified Airlie House Classification used is as follows: Grade 0 - No evidence of hard exudates; Grade 1 - Questionable hard exudates present; Grade 2 - Hard exudates less than standard photograph 3; Grade 3 - Hard exudates greater than or equal to standard photograph 3, but less than standard photograph 5; Grade 4 - Hard exudates greater than or equal to standard photograph 5, but less than standard photograph 4 and Grade 5 - Hard exudates greater than or equal to standard photograph 4. These grades were further divided into three groups of patient severity as follows: Group 1 (absent or minimal hard exudates) included patients with Grade 0, 1 or 2 hard exudates; Group 2 (hard exudates present) included patients with Grade 3 or 4 hard exudates and Group 3 (prominent hard exudates) included patients with Grade 5 hard exudates.
Details regarding various systemic risk factors, namely the age of onset of diabetes, disease duration and treatment history were obtained. The measurement of other systemic parameters like systolic and diastolic blood pressure, blood hemoglobin, glycosylated hemoglobin, serum creatinine, 24-h proteinuria and complete lipid profile including total serum (s.) cholesterol, low-density lipoprotein cholesterol (LDL), high-density lipoprotein cholesterol (HDL), very low-density lipoprotein cholesterol (VLDL) and s. Triglyceride (TG) was performed. The association of above risk factors with the severity of retinal hard exudates was studied using univariate analysis on one-way ANOVA test. The above factors which returned a result of P<0.1 on ANOVA test were further evaluated for their independent association with retinal hard exudates using multiple linear regression analysis. Similarly, Spearman's correlation test was performed to study the correlation between the above risk factors and the severity of retinal hard exudates. Statistically significant levels were assumed at a P value of less than 0.05. We also measured the incidence of dyslipidemia in this group of patients by comparing their s. cholesterol and LDL levels with our laboratory standards for diabetic patients where s.LDL levels >130 mg/dl and s. cholesterol >200 mg/dl are assumed as abnormal.
| :: Results | | |
The study included 180 patients (180 eyes) with nonproliferative diabetic retinopathy (NPDR) and clinically significant macular edema (CSME). There were 116 male patients and 64 female patients. The mean (± standard deviation) age was 55.6 ± 7.4 years. One hundred and twenty-five patients (69.4%) were receiving oral hypoglycemic agents, 50 patients (27.8%) were on insulin therapy and five patients (2.8%) were on dietary control. One hundred and eighteen patients (65.5%) had associated history of hypertension and were under treatment. The mean best-corrected visual acuity in these patients at the time of enrollment was 0.56 units on LogMar scale (range 0.0 to 1.5). On Chi-square test, sex of the patient (P=0.305) and their treatment modality (P=0.166) did not exhibit any significant association with the density of retinal hard exudates.
Thirty-three eyes had hard exudates of Grade 2 or less and were included in Group 1 (absent or minimal hard exudates). Similarly, hard exudates of Grade 3 or 4 were seen in 90 eyes who were included in Group 2 (hard exudates present) while the remaining 57 eyes had Grade 5 hard exudates and were included in Group 3 (prominent hard exudates). The distribution of various parameters among the three groups is provided in [Table 1]. On univariate analysis by one-way ANOVA test, the retinal hard exudates were found to be significantly associated with s. creatinine (P=0.016), systolic blood pressure (P=0.014), s. cholesterol (P<0.001), s. LDL (P=0.008) and s. TG (P=0.013) levels. While on linear regression analysis, s. cholesterol (P<0.001) and s. LDL (P=0.028) were found to be the independent risk factors affecting the severity of retinal hard exudates. On Spearman's correlation test, the retinal hard exudates showed a significant positive correlation with systolic blood pressure (P=0.019), s. cholesterol (P<0.001), s. LDL (P=0.002) and TG (P=0.014) levels.
Among Group 1 patients, six patients (18.2%) had elevated s. LDL levels (>130 mg/dl) while seven patients (21.2%) had elevated s. cholesterol (>200 mg/dl) levels. Among Group 2 patients, 41 patients (45.5%) had elevated s. LDL while 46 patients (51.1%) had elevated s. cholesterol levels. The corresponding figures for Group 3 were 33 patients (57.9%) and 40 patients (70.2%) respectively.
| :: Discussion | | |
Retinal hard exudates usually encountered in patients with diabetic retinopathy result from the leakage of lipoproteins from retinal capillaries into the extracellular space of the retina. As the density of these hard exudates increases, they tend to migrate towards the foveal centre where their deposition predisposes to development of subfoveal fibrosis leading to irreversible visual loss. In fact early treatment diabetic retinopathy study has demonstrated an independent adverse effect of these retinal hard exudates on the visual acuity of the patients. [4],[8]
Previous studies conducted predominantly in the Caucasian white population have shown significant association between retinal hard exudates and the s. cholesterol and LDL levels. [4],[5] Roy and Klein have documented that the presence of proteinuria, male sex, higher LDL-cholesterol levels and longer duration of diabetes are significantly and independently associated with the severity of retinal hard exudates in the African American diabetic population. 6 Subsequently, Miljanovic et al., in a prospective study demonstrated that elevated serum lipids, particularly total-to-HDL cholesterol ratio and triglycerides, are independent risk factors for both CSME and retinal hard exudates. [7]
Type 2 diabetes mellitus (DM) has emerged as a major global public health problem. This is more so in developing countries like India which is expected to bear the brunt of this disease and emerge as the world capital of diabetes mellitus by 2030. [16] In the Indian population, the prevalence of type 2 DM ranges from 2.7% in rural India to nearly 14% in urban India. Previous studies in the north Indian population have documented that they are at a high risk of developing diabetes and its related complications in comparison with other Asian communities. [9],[10],[11],[12],[13],[14] A higher prevalence is, in part, attributed to the genetic predisposition of the individual and to a host of various morphological/biological parameters more commonly seen in our north Indian population like physical inactivity, upper-body adiposity, higher body fat percent, dyslipidemia and exaggerated insulin resistance.
Pradeepa et al., in a study from urban south India, identified higher HbA1c levels, male gender, longer duration of diabetes, macroalbuminuria and insulin therapy as independent risk factors for diabetic retinopathy. [17] Similarly Rani et al., in a mass screening study from southern rural districts of Tamil Nadu identified longer duration of diabetes, lean body mass index (lower BMI), higher systolic blood pressure and insulin treatment as the systemic risk factors significantly associated with referable diabetic retinopathy. [18] However, the above studies did not look into their lipid levels.
The present study suggests that serum cholesterol and LDL levels have a significant and independent effect on the severity of retinal hard exudates. We also observed an increasing incidence of dyslipidemia with progressive grades of hard exudates in this subgroup of diabetic patients with CSME. The limitation of the present study is that since it is based in a tertiary level referral hospital, a majority of the cases are complex and systemically uncontrolled, and hence it may account for the relatively high incidence of dyslipidemia observed. Moreover, the association of BMI of these patients with the observed dyslipidemia and the severity of retinal hard exudates needs to be further evaluated.
The present study suggests that the treating ophthalmologists should get a complete blood lipid profile test done if the patient has significant retinal hard exudates on fundus examination. This study also highlights the need for routine prescription of lipid-lowering drugs in addition to dietary restrictions and regular physical exercise in north Indian diabetic patients with documented retinal hard exudates due to the widespread occurrence of dyslipidemia in these patients. These drugs have already proven beneficial effect in reducing the risk of adverse cardiovascular events like myocardial infarction and stroke. [19],[20]
| :: Acknowledgment | | |
Prof Amod Gupta, Prof and Head, Dept of Ophthalmology, PGIMER. Dr. Vishali Gupta, Associate Prof, Dept of Ophthalmology, PGIMER.
| :: References | | |
| 1. | Klein R, Klein BE, Moss SE, Davis MD, DeMets DL. The Wisconsin epidemiologic study of diabetic retinopathy: IV: Diabetic macular edema. Ophthalmology 1984;91:1464-74.  [PUBMED] |
| 2. | Ciulla TA, Amador AG, Zinman B. Diabetic retinopathy and diabetic macular edema: Pathophysiology, screening, and novel therapies. Diabetes Care 2003;26:2653-64. [PUBMED] [FULLTEXT] |
| 3. | Ferris FL 3rd, Chew EY, Hoogwerf BJ. Serum lipids and diabetic retinopathy: Early Treatment Diabetic Retinopathy Study Research Group. Diabetes Care 1996;19:1291-3. [PUBMED] |
| 4. | Chew EY, Klein ML, Ferris FL 3rd, Remaley NA, Murphy RP, Chantry K, et al. Association of elevated serum lipid levels with retinal hard exudate in diabetic retinopathy: Early Treatment Diabetic Retinopathy Study (ETDRS) report 22. Arch Ophthalmol 1996;114:1079-84. [PUBMED] [FULLTEXT] |
| 5. | Klein BE, Moss SE, Klein R, Surawicz TS. The Wisconsin Epidemiologic Study of Diabetic Retinopathy: XIII: Relationship of serum cholesterol to retinopathy and hard exudate. Ophthalmology 1991;98:1261-5. [PUBMED] |
| 6. | Roy MS, Klein R. Macular edema and retinal hard exudates in African Americans with type 1 diabetes: The New Jersey 725. Arch Ophthalmol 2001;119:251-9. [PUBMED] |
| 7. | Miljanovic B, Glynn RJ, Nathan DM, Manson JE, Schaumberg DA. A prospective study of serum lipids and risk of diabetic macular edema in type 1 diabetes. Diabetes 2004;53:2883-92. [PUBMED] [FULLTEXT] |
| 8. | Fong DS, Segal PP, Myers F, Ferris FL, Hubbard LD, Davis MD. Subretinal fibrosis in diabetic macular edema: ETDRS report 23: Early Treatment Diabetic Retinopathy Study Research Group. Arch Ophthalmol 1997;115:873-7. [PUBMED] [FULLTEXT] |
| 9. | Mohan V, Sandeep S, Deepa R, Shah B, Varghese C. Epidemiology of type 2 diabetes: Indian scenario. Indian J Med Res 2007;125:217-30. [PUBMED] [FULLTEXT] |
| 10. | Ramachandran A, Snehalatha C, Latha E, Vijay V, Vishwanathan M. Rising prevalence of NIDDM in urban population in India. Diabetologia 1997;40:232-7. [PUBMED] [FULLTEXT] |
| 11. | Mathur SK, Chandra P, Mishra S, Ajmera P, Sharma P. Type 2 diabetes related intermediate phenotypic traits in North Indian patients with diabetes. Endocr Pract 2005;11:16. |
| 12. | Ramachandran A, Snehalatha C, Dharmaraj D, Vishwanathan M. Prevalence of glucose intolerance in Asian Indians: Urban-rural difference and significance of upper body adiposity. Diabetes Care 1992;15:1348-55. [PUBMED] |
| 13. | Sharp PS, Mohan V, Levy JC, Mather HM, Kohner EM. Insulin resistance in patients of Asian Indian and European origin with non-insulin dependent diabetes. Horm Metab Res 1987;19:84-5. [PUBMED] [FULLTEXT] |
| 14. | Madhu SV, Mittal V, Ram BK, Srivastava DK. Postprandial lipid abnormalities in type 2 diabetes mellitus. J Assoc Physicians India 2005;53:1043-6. [PUBMED] |
| 15. | Diabetic retinopathy study research group report 7. A modification of the airlie house classification of diabetic retinopathy. Invest Ophthalmol Vis Sci 1981;21:210-26. |
| 16. | Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: Estimates for the year 2000 and projections for 2030. Diabetes Care 2004;2:1047-53. |
| 17. | Pradeepa R, Anitha B, Mohan V, Ganesan A, Rema M. Risk factors for diabetic retinopathy in a South Indian type 2 diabetic population--the Chennai Urban Rural Epidemiology Study (CURES) Eye Study 4. Diabetes Med 2008;25: 536-42. |
| 18. | Rani PK, Raman R, Chandrakantan A, Pal SS, Perumal GM, Sharma T. Risk factors for diabetic retinopathy in self-reported rural population with diabetes. J Postgrad Med 2009;55:92-6. [PUBMED]  |
| 19. | Velussi M. Long-term (18-month) efficacy of atorvastatin therapy in type 2 diabetics at cardiovascular risk. Nutr Metab Cardiovasc Dis 2002;12: 29-35. [PUBMED] |
| 20. | Velussi M, Cernigoi AM, Tortul C, Merni M. Atorvastatin for the management of type 2 diabetic patients with dyslipidaemia: A mid-term (9 months) treatment experience. Diabetes Nutr Metab 1999;12:407-12. [PUBMED] |
[Table 1]
| This article has been cited by | | 1 |
Retinal microvascular changes in diabetic patients with diabetic nephropathy |
|
| Yujie Yan, Liping Yu, Chuan Sun, Haipeng Zhao, Hongsong Zhang, Zhijun Wang | | BMC Endocrine Disorders. 2023; 23(1) | | [Pubmed] | [DOI] | | | 2 |
To study the association of dyslipidemia with macular edema and hard exudates in diabetic maculopathy in an industrial hospital in Chhattisgarh |
|
| Priksha Lakhlan, Chitra Sunov | | Indian Journal of Clinical and Experimental Ophthalmology. 2023; 9(1): 60 | | [Pubmed] | [DOI] | | | 3 |
Sustained ACE2 Expression by Probiotic Improves Integrity of Intestinal Lymphatics and Retinopathy in Type 1 Diabetic Model |
|
| Ram Prasad, Yvonne Adu-Agyeiwaah, Jason L. Floyd, Bright Asare-Bediako, Sergio Li Calzi, Dibyendu Chakraborty, Angela Harbour, Aayush Rohella, Julia V. Busik, Qiuhong Li, Maria B. Grant | | Journal of Clinical Medicine. 2023; 12(5): 1771 | | [Pubmed] | [DOI] | | | 4 |
Do different lipid components accelerate the pathogenesis and severity of Diabetic Retinopathy? |
|
| Lakshmi Kanta Mondal, Subhasish Pramanik, Subhankar Chowdhury, Chiranjit Bose, Debgopal Bera, Ayindrila Saha, Koena Bhattacharjee | | International Journal of Retina and Vitreous. 2022; 8(1) | | [Pubmed] | [DOI] | | | 5 |
GLCM and statistical features extraction technique with Extra-Tree Classifier in Macular Oedema risk diagnosis |
|
| Chinedu I. Ossai, Nilmini Wickramasinghe | | Biomedical Signal Processing and Control. 2022; 73: 103471 | | [Pubmed] | [DOI] | | | 6 |
Quantitative evaluation of hard exudates in diabetic macular edema by multicolor imaging and their associations with serum lipid levels |
|
| Ruowen Gong, Ruyi Han, Jingli Guo, Wei Liu, Gezhi Xu | | Acta Diabetologica. 2021; 58(9): 1161 | | [Pubmed] | [DOI] | | | 7 |
Mfsd2a overexpression alleviates vascular dysfunction in diabetic retinopathy |
|
| Chun-lin Zhang, Hai-ling Wang, Peng-cheng Li, Can-dong Hong, An-qi Chen, Yan-mei Qiu, Ai-ping Zeng, Yi-fan Zhou, Bo Hu, Ya-nan Li | | Pharmacological Research. 2021; 171: 105755 | | [Pubmed] | [DOI] | | | 8 |
A study of systemic factors affecting diabetic retinopathy in type 2 diabetes mellitus |
|
| Renu Mohan Magdum, Saurabh Madhav Oza, Varsha V Manade, Madhuri Khandelwal, Namratha Judith Cardoza | | Indian Journal of Clinical and Experimental Ophthalmology. 2020; 6(2): 244 | | [Pubmed] | [DOI] | | | 9 |
High-Density Lipoprotein Cholesterol in Age-Related Ocular Diseases |
|
| Bjorn Kaijun Betzler, Tyler Hyungtaek Rim, Charumathi Sabanayagam, Chui Ming Gemmy Cheung, Ching-Yu Cheng | | Biomolecules. 2020; 10(4): 645 | | [Pubmed] | [DOI] | | | 10 |
Visual and Morphologic Outcomes in Eyes with Hard Exudate in the Comparison of Age-Related Macular Degeneration Treatments Trials |
|
| Ebenezer Daniel, Juan E. Grunwald, Benjamin J. Kim, Maureen G. Maguire, Glenn J. Jaffe, Cynthia A. Toth, Frederick L. Ferris, Daniel F. Martin, James Shaffer, Gui-Shuang Ying | | Ophthalmology Retina. 2017; 1(1): 25 | | [Pubmed] | [DOI] | | | 11 |
Relationship of Serum HbA1c and Fasting Serum Lipids with Central Macular Thickness in Patients with Type 2 Diabetes Mellitus |
|
| AG Kocak Altintas | | Journal of Clinical Research and Ophthalmology. 2016; : 023 | | [Pubmed] | [DOI] | | | 12 |
STUDY OF ASSOCIATION OF DIABETIC MACULOPATHY WITH HYPERLIPIDEMIA |
|
| Sivaramareddy Kolli, Ananda Reddy Endreddy, Viswas Reddy | | Journal of Evolution of Medical and Dental Sciences. 2015; 4(100): 16506 | | [Pubmed] | [DOI] | | | 13 |
Prevalence of diabetic retinopathy in type 2 diabetics and its correlation with various clinical and metabolic factors |
|
| Mridul Malhotra,Ashok Kumar Lal,Vivek P. Singh,Praveen K. Malik,Vivek Arya,A. K. Agarwal | | International Journal of Diabetes in Developing Countries. 2014; | | [Pubmed] | [DOI] | | | 14 |
Association Between Plasma Triglycerides and High-Density Lipoprotein Cholesterol and Microvascular Kidney Disease and Retinopathy in Type 2 Diabetes Mellitus |
|
| Frank M. Sacks, Michel P. Hermans, Paola Fioretto, Paul Valensi, Timothy Davis, Edward Horton, Christoph Wanner, Khalid Al-Rubeaan, Ronnie Aronson, Isabella Barzon, Louise Bishop, Enzo Bonora, Pongamorn Bunnag, Lee-Ming Chuang, Chaicharn Deerochanawong, Ronald Goldenberg, Benjamin Harshfield, Cristina Hernández, Susan Herzlinger-Botein, Hiroshi Itoh, Weiping Jia, Yi-Der Jiang, Takashi Kadowaki, Nancy Laranjo, Lawrence Leiter, Takashi Miwa, Masato Odawara, Ken Ohashi, Atsushi Ohno, Changyu Pan, Jiemin Pan, Juan Pedro-Botet, Zeljko Reiner, Carlo Maria Rotella, Rafael Simo, Masami Tanaka, Eugenia Tedeschi-Reiner, David Twum-Barima, Giacomo Zoppini, Vincent J. Carey | | Circulation. 2014; 129(9): 999 | | [Pubmed] | [DOI] | | | 15 |
Association of systemic and ocular risk factors with neurosensory retinal detachment in diabetic macular edema: a case–control study |
|
| Aditi Gupta,Rajiv Raman,Vaitheeswaran Kulothungan,Tarun Sharma | | BMC Ophthalmology. 2014; 14(1): 47 | | [Pubmed] | [DOI] | | | 16 |
Quantitative measurement of hard exudates in patients with diabetes and their associations with serum lipid levels |
|
| Sasaki, M. and Kawasaki, R. and Noonan, J.E. and Wong, T.Y. and Lamoureux, E. and Wang, J.J. | | Investigative Ophthalmology and Visual Science. 2013; 54(8): 5544-5549 | | [Pubmed] | | | 17 |
Identifying risk factors for clinically significant diabetic macula edema in patients with type 2 diabetes mellitus |
|
| Kamoi, K. and Takeda, K. and Hashimoto, K. and Tanaka, R. and Okuyama, S. | | Current Diabetes Reviews. 2013; 9(3): 209-217 | | [Pubmed] | | | 18 |
Prevalence and risk factors of diabetic retinopathy in Chongqing pre-diabetes patients |
|
| Chen, X. and Zhao, Y. and Zhou, Z. and Zhang, X. and Li, Q. and Bai, L. and Zhang, M. | | Eye (Basingstoke). 2012; 26(6): 816-820 | | [Pubmed] | | | 19 |
Prevalence and risk factors of diabetic retinopathy in Chongqing pre-diabetes patients |
|
| X Chen,Y Zhao,Z Zhou,X Zhang,Q Li,L Bai,M Zhang | | Eye. 2012; 26(6): 816 | | [Pubmed] | [DOI] | | | 20 |
The relationship between serum lipids and severity of macular Edema in diabetic patients |
|
| Mikaniki, E. and Rasoulinejad, S.A. and GharehDaghly, L. and Shirzadian, A.H. and Bijani, A. | | Journal of Mazandaran University of Medical Sciences. 2011; 20(80): 8-15 | | [Pubmed] | | | 21 |
Sleep - Wake cycles and cognitive functioning in schizophrenia |
|
| eep - Wake cycles and cognitive functioning in schizophrenia | | British Journal of Psychiatry. 2011; 198(4): 269-276 | | [Pubmed] | | | 22 |
Neurocognition and its influencing factors in the treatment of schizophrenia - Effects of aripiprazole, olanzapine, quetiapine and risperidone |
|
| Riedel, M., Schennach-Wolff, R., Musil, R., Dehning, S., Cerovecki, A., Opgen-Rhein, M., Matz, J., (...), Spellmann, I. | | Human Psychopharmacology. 2010; 25(2): 116-125 | | [Pubmed] | | | 23 |
Systematic review on the role of neurocognitive deficits in first-degree relatives of schizophrenic patients | [Revisione sistematica sul ruolo dei deficit neurocognitivi nei familiari di primo grado dei pazienti schizofrenici] |
|
| Scala, S., Lasalvia, A. | | Rivista di Psichiatria. 2010; 45(5): 271-289 | | [Pubmed] | | | 24 |
Reaction time and implicit learning in patients with multiple-episode schizophrenia |
|
| Coman, H., Nemeş, B., Nica, S., Rusu, I., Herţa, D., Cosman, D. | | Journal of Cognitive and Behavioral Psychotherapies. 2010; 10(2): 147-150 | | [Pubmed] | |
|
|
|
|
|
|
|
|
